Clinical Trial: A randomized, single-blind, multicenter Phase II clinical trial to evaluate the efficacy and safety of YH01 Injection in patients with unresectable locally advanced or metastatic head and neck malignancies who have failed standard treatment (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized, single-blind, multicenter Phase II clinical trial to evaluate the efficacy and safety of YH01 Injection in patients with unresectable locally advanced or metastatic head and neck malignancies who have failed standard treatment'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133618

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335854

Published by HT Digital Content Services with permi...